Literature DB >> 3917745

Prolactinomas.

A Grossman, G M Besser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3917745      PMCID： PMC1417897          DOI： 10.1136/bmj.290.6463.182

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  35 in total

Review 1.  Regulation of prolactin secretion by oestrogens: physiological and pathological significance.

Authors:  S Franks
Journal:  Clin Sci (Lond)       Date:  1983-11       Impact factor: 6.124

Review 2.  Pituitary prolactinomas.

Authors:  J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1982-08       Impact factor: 3.478

3.  Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.

Authors:  G T Tindall; K Kovacs; E Horvath; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

4.  High-resolution computed tomographic appearance of the intrasellar contents in women of childbearing age.

Authors:  J D Swartz; K B Russell; B A Basile; P C O'Donnell; G L Popky
Journal:  Radiology       Date:  1983-04       Impact factor: 11.105

5.  Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.

Authors:  H D Breidahl; D J Topliss; J W Pike
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-13

6.  Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.

Authors:  D L Barrow; G T Tindall; K Kovacs; M O Thorner; E Horvath; J C Hoffman
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

7.  Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients.

Authors:  R V Randall; E R Laws; C F Abboud; M J Ebersold; P C Kao; B W Scheithauer
Journal:  Mayo Clin Proc       Date:  1983-02       Impact factor: 7.616

8.  Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.

Authors:  O Serri; E Rasio; H Beauregard; J Hardy; M Somma
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

9.  Bone density in amenorrheic women with and without hyperprolactinemia.

Authors:  J A Schlechte; B Sherman; R Martin
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

10.  Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.

Authors:  S Franks; P M Horrocks; S S Lynch; W R Butt; D R London
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09
View more
  14 in total

Review 1.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

2.  Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.

Authors:  Arijit Chattopadhyay; Anil Bhansali; Shariq R Masoodi
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Hyperprolactinemia in Women of Reproductive Age: Etiology, diagnosis, and management.

Authors:  B H Yuen
Journal:  Can Fam Physician       Date:  1992-02       Impact factor: 3.275

4.  Reversal of severe osteopenia in a patient with hyperprolactinemia treated with bromocriptine.

Authors:  J S Lindberg; F O Kolb; R A Blau; M R Powell
Journal:  West J Med       Date:  1988-09

5.  Hyperprolactinaemia.

Authors:  T H Jones; R L Kennedy
Journal:  BMJ       Date:  1988-11-12

Review 6.  Hyperprolactinaemia.

Authors:  M Hartog; M G Hull
Journal:  BMJ       Date:  1988-09-17

7.  Hyperprolactinemia and temporal lobe epilepsy in a woman: concomitant and persistent prolactin suppression and temporal lobe epilepsy relief.

Authors:  A Gattereau; J Vézina; S Rousseau; P Bielmann
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

8.  The pituitary stalk effect: is it a passing phenomenon?

Authors:  Marvin Bergsneider; Leili Mirsadraei; William H Yong; Noriko Salamon; Michael Linetsky; Marilene B Wang; David L McArthur; Anthony P Heaney
Journal:  J Neurooncol       Date:  2014-02-19       Impact factor: 4.130

9.  Prolactin secreting pituitary carcinoma.

Authors:  T Petterson; I A MacFarlane; J M MacKenzie; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

10.  PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.

Authors:  B J Daemen; R Zwertbroek; P H Elsinga; A M Paans; H Doorenbos; W Vaalburg
Journal:  Eur J Nucl Med       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.